Identification of a serotonin/glutamate receptor complex implicated in psychosis
Open accessThe DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
The psychosis associated with schizophrenia is characterized by alterations in sensory processing and perception. Some antipsychotic drugs were identified by their high affinity for serotonin 5-HT2A receptors (2AR). Drugs that interact with metabotropic glutamate receptors (mGluR) also have potential for the treatment of schizophrenia. The effects of hallucinogenic drugs, such as psilocybin and lysergic acid diethylamide, require the 2AR and resemble some of the core symptoms of schizophrenia. Here we show that the mGluR2 interacts through specific transmembrane helix domains with the 2AR, a member of an unrelated G-protein-coupled receptor family, to form functional complexes in brain cortex. The 2AR-mGluR2 complex triggers unique cellular responses when targeted by hallucinogenic drugs, and activation of mGluR2 abolishes hallucinogen-specific signalling and behavioural responses. In post-mortem human brain from untreated schizophrenic subjects, the 2AR is upregulated and the mGluR2 is downregulated, a pattern that could predispose to psychosis. These regulatory changes indicate that the 2AR-mGluR2 complex may be involved in the altered cortical processes of schizophrenia, and this complex is therefore a promising new target for the treatment of psychosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Furthermore, the 5HT2A receptor forms a functional heterodimer with the mGluR2 receptor, which evokes allosteric effects on serotonin agonist binding [34];”
From Molecular and Functional Imaging Studies of Psychedelic Drug Action in Animals and Humans. (2021) · cites this paper as [34]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“this interaction reduces the hallucinogen-specific Gi/o protein signaling and behavior and may account for the lack of hallucinogenic action of 2-bromo-LSD (5) noted above.”
From Molecular and Functional Imaging Studies of Psychedelic Drug Action in Animals and Humans. (2021) · cites this paper as [34]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Temporal pattern encoding relieves the cellular information bottleneck, where many stimuli must signal through few intracellular pathways to generate diverse and specific cellular responses (30 -32) but complicates the relationship between synthetic target modulators and their cellular and clinical effects.”
From Cytokine Response Is Determined by Duration of Receptor and Signal Transducers and Activators of Transcription 3 (STAT3) Activation (2013) · cites this paper as [31]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Several recent studies of drugs acting at cell surface receptor targets show that the activation mechanisms responsible for their cellular and systemic effects are more complex than accounted for by their classical pharmacological profiles (30 -32).”
From Cytokine Response Is Determined by Duration of Receptor and Signal Transducers and Activators of Transcription 3 (STAT3) Activation (2013) · cites this paper as [31]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. (2013) · Encyclopedia of Social Work · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,519
Basic local alignment search tool
Altschul, S. F., Gish, W., Miller, W., Myers, E. W., & Lipman, D. J. (1990) · Journal of Molecular Biology · doi:10.1006/jmbi.1990.9999 · Cited by 98,669
Thompson, J. D., Higgins, D. G., & Gibson, T. J. (1994) · Nucleic Acids Research · doi:10.1093/nar/22.22.4673 · Cited by 64,617
Comparative Protein Modelling by Satisfaction of Spatial Restraints
Šali, A., & Blundell, T. L. (1993) · Journal of Molecular Biology · doi:10.1006/jmbi.1993.1626 · Cited by 12,977
Crystal Structure of Rhodopsin: A G Protein-Coupled Receptor
Palczewski, K., Kumasaka, T., Hori, T., Behnke, C. A., Motoshima, H., Fox, B. A., Trong, I. L., Teller, D. C., Okada, T., Stenkamp, R. E., et al. (2000) · Science · doi:10.1126/science.289.5480.739 · Cited by 5,637
High-Resolution Crystal Structure of an Engineered Human β 2 -Adrenergic G Protein–Coupled Receptor
Cherezov, V., Rosenbaum, D. M., Hanson, M. A., Rasmussen, S. G. F., Thian, F. S., Kobilka, T. S., Choi, H.-J., Kuhn, P., Weis, W. I., Kobilka, B. K., et al. (2007) · Science · doi:10.1126/science.1150577 · Cited by 3,264
Patil, S. T., Zhang, L., Martenyi, F., Lowe, S. L., Jackson, K. A., Andreev, B. V., Avedisova, A. S., Bardenstein, L. M., Gurovich, I. Y., Morozova, M. A., et al. (2007) · Nature Medicine · doi:10.1038/nm1632 · Cited by 1,040
Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action
Vollenweider, F. X., Vollenweider-Scherpenhuyzen, M. F. I., Bäbler, A., Vogel, H., & Hell, D. (1998) · NeuroReport · doi:10.1097/00001756-199812010-00024 · Cited by 1,018
Miyamoto, S., Duncan, G. E., Marx, C. E., & Lieberman, J. A. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001556 · Cited by 988
González-Maeso, J., Weisstaub, N. V., Zhou, M., Chan, P., Ivic, L., Ang, R., Lira, A., Bradley-Moore, M., Ge, Y., Zhou, Q., et al. (2007) · Neuron · doi:10.1016/j.neuron.2007.01.008 · Cited by 925
Self-citation
Cited by
Metabotropic Glutamate Receptors: Physiology, Pharmacology, and Disease
Niswender, C. M., & Conn, P. J. (2010) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.011008.145533 · Cited by 1,892
Nichols, D. E. (2016) · Pharmacological Reviews · doi:10.1124/pr.115.011478 · Cited by 1,762
“Although the in vivo functional interaction between 5-HT2A receptors and mGlu2 receptors is now widely accepted, González-Maeso et al. (2008) proposed that the 5-HT2A receptor formed a heterodimer with the 294 Nichols”
BackgroundInfluentialMetabotropic glutamate receptors: From the workbench to the bedside
Nicoletti, F., Bockaert, J., Collingridge, G. L., Conn, P. J., Ferraguti, F., Schoepp, D. D., Wroblewski, J. T., & Pin, J. P. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.10.022 · Cited by 653
“González-Maeso et al. (2008) have shown that mGlu2 and 5-HT2A receptors form a heterodimeric complex in the cell membrane, and that activation of mGlu2 receptors inhibits a particular signalling pathway activated by 5- HT2A receptors in response to hallucinogens.”
BackgroundCurrent Concepts and Treatments of Schizophrenia
Stępnicki, P., Kondej, M., & Kaczor, A. A. (2018) · Molecules · doi:10.3390/molecules23082087 · Cited by 556
“Regarding other dimers with possible involvement in the pathomechanism of schizophrenia, mGluR2–5-HT2A heteromer should be mentioned [172] This complex displays unique signaling when interacting with hallucinogenic drugs and activation of mGluR2 cancels hallucinogenic signaling and related behavioral responses.”
BackgroundKenakin, T., & Miller, L. J. (2010) · Pharmacological Reviews · doi:10.1124/pr.108.000992 · Cited by 573
Psychedelic drugs: neurobiology and potential for treatment of psychiatric disorders
Vollenweider, F. X., & Preller, K. H. (2020) · Nature Reviews Neuroscience · doi:10.1038/s41583-020-0367-2 · Cited by 570
Akt/GSK3 Signaling in the Action of Psychotropic Drugs
Beaulieu, J.-M., Gainetdinov, R. R., & Caron, M. G. (2009) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.011008.145634 · Cited by 522
Studerus, E., Kometer, M., Hasler, F., & Vollenweider, F. X. (2011) · Journal of Psychopharmacology · doi:10.1177/0269881110382466 · Cited by 532
Lesch, K.-P., & Waider, J. (2012) · Neuron · doi:10.1016/j.neuron.2012.09.013 · Cited by 435
Acute Effects of Lysergic Acid Diethylamide in Healthy Subjects
Schmid, Y., Enzler, F., Gasser, P., Grouzmann, E., Preller, K. H., Vollenweider, F. X., Brenneisen, R., Müller, F., Borgwardt, S., & Liechti, M. E. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.11.015 · Cited by 411
“Serotoninergic hallucinogens, including LSD, are hypothesized to act at the 5-HT2A receptor (2,54), which is upregulated in patients with schizophrenia (72).”
BackgroundSerotonin research: contributions to understanding psychoses
GEYER, M., & VOLLENWEIDER, F. (2008) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2008.06.006 · Cited by 427
“Specifically, studies [ 56 ] have now indicated that the mGlu2 and 5-HT2A receptors might be co-localized on cortical neurons andthatactivationofthemGlu2componentofthisreceptor complex eliminates the hallucinogen-specific signaling normally produced by LSD via as-yet-unknown mechanisms.”
The role of serotonin 5-HT2A receptors in memory and cognition
Zhang, G., & Stackman, R. W. (2015) · Frontiers in Pharmacology · doi:10.3389/fphar.2015.00225 · Cited by 382
Building a new conceptual framework for receptor heteromers
Ferré, S., Baler, R., Bouvier, M., Caron, M. G., Devi, L. A., Durroux, T., Fuxe, K., George, S. R., Javitch, J. A., Lohse, M. J., et al. (2009) · Nature Chemical Biology · doi:10.1038/nchembio0309-131 · Cited by 394
Self-citationKometer, M., Schmidt, A., Jancke, L., & Vollenweider, F. X. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.3007-12.2013 · Cited by 355
Signaling at G-protein-coupled serotonin receptors: recent advances and future research directions
MILLAN, M., MARIN, P., BOCKAERT, J., & MANNOURYLACOUR, C. (2008) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2008.06.007 · Cited by 320
G protein‐coupled receptor hetero‐dimerization: contribution to pharmacology and function
Milligan, G. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00169.x · Cited by 325
Self-citationHallucinogens and Serotonin 5-HT2A Receptor-Mediated Signaling Pathways
López-Giménez, J. F., & González-Maeso, J. (2017) · Current Topics in Behavioral Neurosciences · doi:10.1007/7854_2017_478 · Cited by 299
“Interestingly, previous findings suggest that the Gq/11-coupled 5-HT2A receptor and the Gi/o-coupled mGlu2 receptor form a specific GPCR heteromeric complex in heterologous expression systems, as well as in mouse and human frontal cortex (Gonzalez-Maeso et al. 2008; Moreno et al. 2012; Fribourg et al. 2011); these res…”
BackgroundResultInfluentialSelf-citationDoumazane, E., Scholler, P., Zwier, J. M., Trinquet, E., Rondard, P., & Pin, J. (2011) · The FASEB Journal · doi:10.1096/fj.10-163147 · Cited by 324
“However, only few studies (19–21) bring clear evidence for the existence of such complexes at the cell surface, and when heteromers are identified, it is often unknown whether they are limited to strict heterodimers or whether they correspond to the association of different homodimers or even higherorder homooligomers…”
BackgroundRecent advances in the neuropsychopharmacology of serotonergic hallucinogens
Halberstadt, A. L. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.07.016 · Cited by 312
“Evidence has emerged that mGlu2 and 5- HT2A receptors can form heteromeric complexes in cortex (Gonzalez-Maeso et al., 2008; Moreno et al., 2012), and these complexes may mediate the crosstalk that occurs between these receptors.”
BackgroundFribourg, M., Moreno, J. L., Holloway, T., Provasi, D., Baki, L., Mahajan, R., Park, G., Adney, S. K., Hatcher, C., Eltit, J. M., et al. (2011) · Cell · doi:10.1016/j.cell.2011.09.055 · Cited by 311
“We postulated that alterations in 2AR and mGluR2 expression levels in our system (Figures 1F and S3D) may model the alterations in 2AR and mGluR2 ratios observed in postmortem brain samples from untreated schizophrenic patients (González-Maeso et al., 2008).”
BackgroundMethodResultInfluentialSelf-citationdos Santos, R. G., Osório, F. L., Crippa, J. A. S., Riba, J., Zuardi, A. W., & Hallak, J. E. C. (2016) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125316638008 · Cited by 306
Epigenetic principles and mechanisms underlying nervous system functions in health and disease
MEHLER, M. (2008) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2008.10.001 · Cited by 291
“…and glutamate (mGluR2) receptor signaling pathways that regulate neocortical sensory gating and are the targets of atypical neuroleptic agents are differentially altered in major psychosis, including post-mortem brains of untreated schizophrenics (Gonzalez-Maeso et al., 2008; Snyder, 2008).”
BackgroundThe discovery of central monoamine neurons gave volume transmission to the wired brain
Fuxe, K., Dahlström, A. B., Jonsson, G., Marcellino, D., Guescini, M., Dam, M., Manger, P., & Agnati, L. (2010) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2009.10.012 · Cited by 285
“schizophrenia development (Gonzalez-Maeso et al., 2008), for review see (Fuxe et al.”
BackgroundControl of lymphocyte egress from lymph nodes through β2-adrenergic receptors
Nakai, A., Hayano, Y., Furuta, F., Noda, M., & Suzuki, K. (2014) · Journal of Experimental Medicine · doi:10.1084/jem.20141132 · Cited by 290
“Previous studies showed that stimulation of 2ARs in dendritic cells reduced their capacities for antigen presentation and production of proinflammatory cytokines, including IL-6, IL-12, and IL-23 (Grebe et al., 2009; Hu et al., 2012; Hervé et al., 2013; Nijhuis et al., 2014).”
BackgroundThe glutamate hypothesis of schizophrenia: evidence from human brain tissue studies
Hu, W., MacDonald, M. L., Elswick, D. E., & Sweet, R. A. (2015) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12547 · Cited by 286
HDAC2 regulates atypical antipsychotic responses through the modulation of mGlu2 promoter activity
Kurita, M., Holloway, T., García-Bea, A., Kozlenkov, A., Friedman, A. K., Moreno, J. L., Heshmati, M., Golden, S. A., Kennedy, P. J., Takahashi, N., et al. (2012) · Nature Neuroscience · doi:10.1038/nn.3181 · Cited by 285
Self-citationNeuroplasticity as a convergent mechanism of ketamine and classical psychedelics
Aleksandrova, L. R., & Phillips, A. G. (2021) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2021.08.003 · Cited by 276
Psilocybin – Summary of knowledge and new perspectives
Tylš, F., Páleníček, T., & Horáček, J. (2014) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2013.12.006 · Cited by 276
“More evidence of the role of these receptors in psychosis is given by the fact that an increased 14 amount of 5-HT2A receptors was described in the cortex of young untreated subjects with schizophrenia postmortem (Gonzalez-Maeso et al., 2008; Muguruza et al., 2013).”
BackgroundBarnes, N. M., Ahern, G. P., Becamel, C., Bockaert, J., Camilleri, M., Chaumont-Dubel, S., Claeysen, S., Cunningham, K. A., Fone, K. C., Gershon, M., et al. (2021) · Pharmacological Reviews · doi:10.1124/pr.118.015552 · Cited by 263
Allostery at G Protein-Coupled Receptor Homo- and Heteromers: Uncharted Pharmacological Landscapes
Smith, N. J., & Milligan, G. (2010) · Pharmacological Reviews · doi:10.1124/pr.110.002667 · Cited by 262
“Using single molecule total internal reflectance fluorescence microscopy, Hern et al., (2010) demonstrated 1Abbreviations: 5-HT, 5-hydroxytryptamine (serotonin); 6 GNTI, 6 - guanidinonaltrindole; 7TM, seven transmembrane; AT1, angiotensin type 1 receptor; BLT1, leukotriene B4 receptor; BRET, bioluminescence resonance…”
InfluentialSelf-citationNeuropharmacology of N,N-dimethyltryptamine
Carbonaro, T. M., & Gatch, M. B. (2016) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2016.04.016 · Cited by 268
“It has been suggested that the heteroreceptors induce a psychedelic-specific second messenger cascade (Gonzalez-Maeso et al., 2007; 2008), although this has not been definitively established (Delille et al., 2012).”
BackgroundG protein-coupled receptor heteromers
Gomes, I., Ayoub, M. A., Fujita, W., Jaeger, W. C., Pfleger, K. D. G., & Devi, L. A. (2016) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-011613-135952 · Cited by 262
“, 5-HT2A-mGlu2 (55), δOR-CB1 (56), β1AR-β2AR (57), and β2ARprostaglandin E2 receptor 1 (EP1R) (58)]; (b) an agonist of one protomer signals through a different G protein subunit in cells expressing the heteromer compared with cells that express the homomer [e.”
BackgroundMoreno, J. L., Holloway, T., Albizu, L., Sealfon, S. C., & González-Maeso, J. (2011) · Neuroscience Letters · doi:10.1016/j.neulet.2011.01.046 · Cited by 234
“3A and B), and the fraction of high-affinity binding site is decreased when R*G complexes are uncoupled by the non-hydrolyzable analog of guanosine triphosphate GTPγS [14,15].”
BackgroundResultSelf-citationDimers and beyond: The functional puzzles of class C GPCRs
Kniazeff, J., Prézeau, L., Rondard, P., Pin, J.-P., & Goudet, C. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.01.006 · Cited by 251
Emerging mechanisms and treatments for depression beyond SSRIs and SNRIs
Dale, E., Bang-Andersen, B., & Sánchez, C. (2015) · Biochemical Pharmacology · doi:10.1016/j.bcp.2015.03.011 · Cited by 234
Canal, C. E., & Morgan, D. (2012) · Drug Testing and Analysis · doi:10.1002/dta.1333 · Cited by 221
“Notably, it was recently discovered that 5-HT2A and mGluR2 receptors form heteromeric complexes that have unique signalling properties.([137])”
Psychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanisms
Inserra, A., De Gregorio, D., & Gobbi, G. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000056 · Cited by 232
An epigenetic framework for neurodevelopmental disorders: From pathogenesis to potential therapy
Millan, M. J. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.11.015 · Cited by 229
Classic hallucinogens in the treatment of addictions
Bogenschutz, M. P., & Johnson, M. W. (2016) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2015.03.002 · Cited by 226
“The metabotropic glutamate mGlu2 receptor, which forms complexes with 5HT2A receptors, is necessary for the pharmacological and behavioral effects of hallucinogenic 5-HT2A agonists (Gonzalez-Maeso et al., 2008; Moreno et al., 2011).”
Selvaraj, S., Arnone, D., Cappai, A., & Howes, O. (2014) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2014.06.005 · Cited by 223
Rescue of defective G protein–coupled receptor function in vivo by intermolecular cooperation
Rivero-Müller, A., Chou, Y.-Y., Ji, I., Lajic, S., Hanyaloglu, A. C., Jonas, K., Rahman, N., Ji, T. H., & Huhtaniemi, I. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0906695106 · Cited by 210
Psychedelic-inspired drug discovery using an engineered biosensor
Dong, C., Ly, C., Dunlap, L. E., Vargas, M. V., Sun, J., Hwang, I.-W., Azinfar, A., Oh, W. C., Wetsel, W. C., Olson, D. E., et al. (2021) · Cell · doi:10.1016/j.cell.2021.03.043 · Cited by 213
Brain serotonergic circuitries
Charnay, Y., & Leger, L. (2010) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2010.12.4/ycharnay · Cited by 210
Validating transcripts with probes and imaging technology
Itzkovitz, S., & van Oudenaarden, A. (2011) · Nature Methods · doi:10.1038/nmeth.1573 · Cited by 203
Renner, U., Zeug, A., Woehler, A., Niebert, M., Dityatev, A., Dityateva, G., Gorinski, N., Guseva, D., Abdel-Galil, D., Fröhlich, M., et al. (2012) · Journal of Cell Science · doi:10.1242/jcs.101337 · Cited by 197
“The clinical significance of GPCR oligomerization has also become more evident in recent years, leading to identification of receptor oligomers as a novel important therapeutic target (Waldhoer et al., 2005; González-Maeso et al., 2008).”
BackgroundInfluentialMolecular targets of atypical antipsychotics: From mechanism of action to clinical differences
Aringhieri, S., Carli, M., Kolachalam, S., Verdesca, V., Cini, E., Rossi, M., McCormick, P. J., Corsini, G. U., Maggio, R., & Scarselli, M. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.06.012 · Cited by 199
Effect of Psilocybin on Empathy and Moral Decision-Making
Pokorny, T., Preller, K. H., Kometer, M., Dziobek, I., & Vollenweider, F. X. (2017) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyx047 · Cited by 197
Ligand-regulated oligomerization of β2-adrenoceptors in a model lipid bilayer
Fung, J. J., Deupi, X., Pardo, L., Yao, X. J., Velez-Ruiz, G. A., DeVree, B. T., Sunahara, R. K., & Kobilka, B. K. (2009) · The EMBO Journal · doi:10.1038/emboj.2009.267 · Cited by 181
“…spectrum of Family A GPCRs using a variety of techniques (Jordan and Devi, 1999; Angers et al, 2000; Gines et al, 2000; Rocheville et al, 2000; Cheng and Miller, 2001; Mellado et al, 2001; Latif et al, 2002; Salahpour et al, 2004; Gonzalez-Maeso et al, 2008; Guo et al, 2008; Vilardaga et al, 2008).”
Potential Psychiatric Applications of Metabotropic Glutamate Receptor Agonists and Antagonists
Krystal, J. H., Mathew, S. J., DʼSouza, D. C., Garakani, A., Gunduz-Bruce, H., & Charney, D. S. (2010) · CNS Drugs · doi:10.2165/11533230-000000000-00000 · Cited by 180
Psychedelics and schizophrenia
González-Maeso, J., & Sealfon, S. C. (2009) · Trends in Neurosciences · doi:10.1016/j.tins.2008.12.005 · Cited by 166
Self-citationSubtypes of functional α1-adrenoceptor
Docherty, J. R. (2010) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-009-0174-4 · Cited by 171
Does stimulation of 5-HT1A receptors improve cognition in schizophrenia?
Meltzer, H. Y., & Sumiyoshi, T. (2008) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.05.016 · Cited by 172
De Deurwaerdère, P., & Di Giovanni, G. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2016.03.004 · Cited by 163
“In particular, it has been proposed that the link between glutamate mGlu2 and 5-HT2A receptors played an important role in cognition (Delille et al., 2013; Gonzalez-Maeso et al., 2008).”
BackgroundKinon, B. J., Millen, B. A., Zhang, L., & McKinzie, D. L. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.03.016 · Cited by 169
Behavioral and physiological effects of acute ketamine exposure in adult zebrafish
Riehl, R., Kyzar, E., Allain, A., Green, J., Hook, M., Monnig, L., Rhymes, K., Roth, A., Pham, M., Razavi, R., et al. (2011) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2011.05.011 · Cited by 163
“number of species, including zebrafish [10,12,15,34,46,54,77,92].”
Braun, D. A., Fribourg, M., & Sealfon, S. C. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.386573 · Cited by 168
Self-citationAyahuasca, dimethyltryptamine, and psychosis: a systematic review of human studies
dos Santos, R. G., Bouso, J. C., & Hallak, J. E. C. (2017) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125316689030 · Cited by 168
“The agonism of these compounds at cortical 5-HT2A receptors also seems to depend on metabotropic glutamate receptors (mGluR) [Gonzalez-Maeso et al. 2008; Moreno et al. 2011].”
BackgroundLevitz, J., Habrian, C., Bharill, S., Fu, Z., Vafabakhsh, R., & Isacoff, E. Y. (2016) · Neuron · doi:10.1016/j.neuron.2016.08.036 · Cited by 167
“In contrast, a recent cross-linking study suggested that activation reorients a TMD interface involving TM4, TM5, and TM6 (Xue et al., 2015), and other studies have indicated that mGluR2 can interact with the 5-HT2A serotonin receptor via TM4 (González-Maeso et al., 2008; Moreno et al., 2012).”
New targets for rapid antidepressant action
Machado-Vieira, R., Henter, I. D., & Zarate Jr., C. A. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.12.001 · Cited by 154
AT1R–CB1R heteromerization reveals a new mechanism for the pathogenic properties of angiotensin II
Rozenfeld, R., Gupta, A., Gagnidze, K., Lim, M. P., Gomes, I., Ramos‐Ortolaza, D. L., Nieto, N., & Devi, L. A. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.139 · Cited by 171
Animal Models of Serotonergic Psychedelics
Hanks, J. B., & González-Maeso, J. (2013) · ACS Chemical Neuroscience · doi:10.1021/cn300138m · Cited by 156
Self-citationDale, E., Pehrson, A. L., Jeyarajah, T., Li, Y., Leiser, S. C., Smagin, G., Olsen, C. K., & Sanchez, C. (2016) · CNS Spectrums · doi:10.1017/s1092852915000425 · Cited by 148
Glutamatergic transmission in drug reward: implications for drug addiction
D'Souza, M. S. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00404 · Cited by 142
G-protein-coupled receptor-focused drug discovery using a target class platform approach
Heilker, R., Wolff, M., Tautermann, C. S., & Bieler, M. (2009) · Drug Discovery Today · doi:10.1016/j.drudis.2008.11.011 · Cited by 155
Wood, J., Kim, Y., & Moghaddam, B. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.6377-11.2012 · Cited by 153
“…although these drugs act on different receptor and neurotransmitter systems, they all disrupt PFC information processing by disinhibiting pyramidal cells (Aghajanian and Marek, 2000; Lewis and Moghaddam, 2006; Gray and Roth, 2007a,b; González-Maeso et al., 2008; González-Maeso and Sealfon, 2009).”
BackgroundInfluentialSchellekens, H., van Oeffelen, W. E. P. A., Dinan, T. G., & Cryan, J. F. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.382473 · Cited by 152
Heteromeric MT 1 /MT 2 Melatonin Receptors Modulate Photoreceptor Function
Baba, K., Benleulmi-Chaachoua, A., Journé, A.-S., Kamal, M., Guillaume, J.-L., Dussaud, S., Gbahou, F., Yettou, K., Liu, C., Contreras-Alcantara, S., et al. (2013) · Science Signaling · doi:10.1126/scisignal.2004302 · Cited by 144
Biochemical Mechanisms Underlying Psychedelic-Induced Neuroplasticity
Olson, D. E. (2022) · Biochemistry · doi:10.1021/acs.biochem.1c00812 · Cited by 129
Prasanna, X., Chattopadhyay, A., & Sengupta, D. (2014) · Biophysical Journal · doi:10.1016/j.bpj.2014.02.002 · Cited by 163
“GPCR oligomerization implies an increased cross talk between receptors via homo- and/or heterodimers as well as higher-order oligomers (10,13,15).”
Pokorny, T., Preller, K. H., Krähenmann, R., & Vollenweider, F. X. (2016) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2016.01.005 · Cited by 156
“…and animal studies that the core psychological effects of psilocybin are primarily mediated via 5-HT2A receptor activation, although serotonergic hallucinogens interact with multiple serotonin receptor sites (González-Maeso et al., 2008, 2007; Halberstadt et al., 2011; Vollenweider et al., 1998).”
BackgroundMarek, G. J., Behl, B., Bespalov, A., Groß, G., Lee, Y., & Schoemaker, H. (2009) · Molecular Pharmacology · doi:10.1124/mol.109.059865 · Cited by 165
Exploring a role for heteromerization in GPCR signalling specificity
Rozenfeld, R., & Devi, L. A. (2010) · Biochemical Journal · doi:10.1042/bj20100458 · Cited by 144
Shen, Y., Noetzel, M. J., Johnson, K. A., Zamorano, R., Jalan‐Sakrikar, N., Gregory, K. J., Conn, P. J., & Niswender, C. M. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.1129-13.2014 · Cited by 151
“For example, González-Maeso et al. (2008) reported that 5-HT2A receptors interact with mGlu2 and form functional complexes in cerebral cortex.”
BackgroundMoreno, J. L., Muguruza, C., Umali, A., Mortillo, S., Holloway, T., Pilar-Cuéllar, F., Mocci, G., Seto, J., Callado, L. F., Neve, R. L., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.413161 · Cited by 140
“We have also shown that the segment containing TM4 and TM5 of mGlu2 is necessary for this receptor to be assembled as a heterocomplex with the 5-HT2A receptor (13, 16).”
BackgroundMethodInfluentialSelf-citationAsan, E., Steinke, M. R., & Lesch, K. (2013) · Histochemistry and Cell Biology · doi:10.1007/s00418-013-1081-1 · Cited by 158
Adenosine–cannabinoid receptor interactions. Implications for striatal function
Ferré, S., Lluís, C., Justinova, Z., Quiroz, C., Orru, M., Navarro, G., Canela, E. I., Franco, R., & Goldberg, S. R. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00723.x · Cited by 129
Targeting metabotropic glutamate receptors for novel treatments of schizophrenia
Maksymetz, J., Moran, S. P., & Conn, P. J. (2017) · Molecular Brain · doi:10.1186/s13041-017-0293-z · Cited by 147
Central serotonin-2A (5-HT2A) receptor dysfunction in depression and epilepsy: the missing link?
Guiard, B. P., & Giovanni, G. D. (2015) · Frontiers in Pharmacology · doi:10.3389/fphar.2015.00046 · Cited by 131
“…stable homo- (Herrick-Davis et al., 2005; Brea et al., 2009) and heteromeric complexes with other types of GPCRs including the mGluR2 and D2-DA Rs (González-Maeso et al., 2008; Albizu et al., 2011; Fribourg et al., 2011; Lukasiewicz et al., 2011; Moreno et al., 2011; Delille et al., 2012; Moreno…”
BackgroundInterplay between Serotonin 5‐HT1Aand 5‐HT7Receptors in Depressive Disorders
Naumenko, V. S., Popova, N. K., Lacivita, E., Leopoldo, M., & Ponimaskin, E. G. (2014) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12247 · Cited by 130
“The clinical significance of GPCR oligomerization has also become more evident during recent years, leading to identification of oligomeric complexes as novel therapeutic targets [89,90].”
BackgroundReceptor heteromerization and drug discovery
Rozenfeld, R., & Devi, L. A. (2010) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2009.11.008 · Cited by 130
“These studies demonstrated the existence of multiple interaction interfaces, including TM1 and TM4 in the D2R homomer [49] and identified mGluR2 TM 4/5 as the dimerization interface with 5HT2aR in the 5HT2aR-mGluR2 complex [30].”
BackgroundMethodConvergence of Melatonin and Serotonin (5-HT) Signaling at MT2/5-HT2C Receptor Heteromers
Kamal, M., Gbahou, F., Guillaume, J.-L., Daulat, A. M., Benleulmi-Chaachoua, A., Luka, M., Chen, P., Kalbasi Anaraki, D., Baroncini, M., Mannoury la Cour, C., et al. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.559542 · Cited by 128
Carbonaro, T. M., Johnson, M. W., Hurwitz, E., & Griffiths, R. R. (2018) · Psychopharmacology · doi:10.1007/s00213-017-4769-4 · Cited by 133
Crosstalk between GABAB and mGlu1a receptors reveals new insight into GPCR signal integration
Rives, M., Vol, C., Fukazawa, Y., Tinel, N., Trinquet, E., Ayoub, M. A., Shigemoto, R., Pin, J., & Prézeau, L. (2009) · The EMBO Journal · doi:10.1038/emboj.2009.177 · Cited by 133
“Furthermore, in rat, the oligomeriza- tion of the metabotropic glutamate receptor type 2 (mGlu2) and the serotonin receptor 5-HT2A has recently been shown to control the action of hallucinogens in the prefrontal cortex (Gonzalez-Maeso et al, 2008).”
BackgroundInfluentialMolecular Mechanisms of Psilocybin and Implications for the Treatment of Depression
Ling, S., Ceban, F., Lui, L. M. W., Lee, Y., Teopiz, K. M., Rodrigues, N. B., Lipsitz, O., Gill, H., Subramaniapillai, M., Mansur, R. B., et al. (2022) · CNS Drugs · doi:10.1007/s40263-021-00877-y · Cited by 127
“Additionally, administration of DOI in mGlu2-knockout mice over-expressing a chimeric mGlu2 construct which cannot be complexed with 5-HT2ARs in the frontal cortex did not restore head-twitch behavior [50, 51].”
BackgroundFranco, R., Martínez‐Pinilla, E., Lanciego, J. L., & Navarro, G. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00076 · Cited by 139
Cholinergic connectivity: it's implications for psychiatric disorders
Scarr, E., Gibbons, A. S., Neo, J., Udawela, M., & Dean, B. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00055 · Cited by 119
“, 2011), cortical binding of [3H]LY341495, another mGluR2/mGluR3 selective ligand, and mGluR2 but not mGluR3 mRNA has been reported to be decreased in subjects with schizophrenia, 84% of whom died by suicide (Gonzalez-Maeso et al., 2008).”
BackgroundResultMoreno, J. L., Kurita, M., Holloway, T., López, J., Cadagan, R., Martínez-Sobrido, L., García-Sastre, A., & González-Maeso, J. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.4230-10.2011 · Cited by 120
“Expression level was significantly higher for 5-HT2A ( p 0.05; Student’s t test) and significantly lower for mGlu2 (González-Maeso et al., 2008).”
BackgroundInfluentialSelf-citationHolloway, T., Moreno, J. L., Umali, A., Rayannavar, V., Hodes, G. E., Russo, S. J., & González-Maeso, J. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.2331-12.2013 · Cited by 123
Self-citationFunctional crosstalk and heteromerization of serotonin 5-HT2A and dopamine D2 receptors
Albizu, L., Holloway, T., González-Maeso, J., & Sealfon, S. C. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.05.023 · Cited by 119
“Competition binding assays can provide a sensitive measure of functional interactions within a receptor complex (Gonzalez-Maeso et al., 2008).”
BackgroundMethodSelf-citationThe role of serotonin in the NMDA receptor antagonist models of psychosis and cognitive impairment
Meltzer, H. Y., Horiguchi, M., & Massey, B. W. (2011) · Psychopharmacology · doi:10.1007/s00213-010-2137-8 · Cited by 134
Serotonergic Hallucinogen-Induced Visual Perceptual Alterations
Kometer, M., & Vollenweider, F. X. (2016) · Current topics in behavioral neurosciences · doi:10.1007/7854_2016_461 · Cited by 139
“…induces a robust increase in excitatory postsynaptic currents (EPSCs) of pyramidal neurons, predominantly within layer 5 of the frontal cortical area (Aghajanian and Marek 1997; Béïque et al. 2007; González-Maeso et al. 2007, 2008; Riga et al. 2014) and occipital cortex (Moreau et al. 2010).”
BackgroundErrico, F., Rossi, S., Napolitano, F., Catuogno, V., Topo, E., Fisone, G., D’Aniello, A., Centonze, D., & Usiello, A. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.1618-08.2008 · Cited by 129
“It has been proposed that dysfunction of dopaminergic neurotransmission occurs in SCZ patients (Snyder, 1976); however, a large body of evidence recently proposed that abnormal serotonergic and glutamatergic neurotransmission might also be implicated in the pathophysiological processes leading to the development of sc…”
BackgroundMembrane Driven Spatial Organization of GPCRs
Mondal, S., Johnston, J. M., Wang, H., Khelashvili, G., Filizola, M., & Weinstein, H. (2013) · Scientific Reports · doi:10.1038/srep02909 · Cited by 119
Self-citationHetero-dimerization of serotonin 5-HT2A and dopamine D2 receptors
Łukasiewicz, S., Polit, A., Kędracka–Krok, S., Wędzony, K., Maćkowiak, M., & Dziedzicka‐Wasylewska, M. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2010.08.010 · Cited by 123
“in psychosis [78].”
Abi-Dargham, A., Xu, X., Thompson, J. L., Gil, R., Kegeles, L. S., Urban, N., Narendran, R., Hwang, D.-R., Laruelle, M., & Slifstein, M. (2012) · Journal of Psychopharmacology · doi:10.1177/0269881111409265 · Cited by 120
Navarro, G., Ferré, S., Cordomí, A., Moreno, E., Mallol, J., Casadó, V., Cortés, A., Hoffmann, H. M., Ortiz, J., Canela, E. I., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.115634 · Cited by 128
Effect of Hallucinogens on Unconditioned Behavior
Halberstadt, A. L., & Geyer, M. A. (2016) · Current Topics in Behavioral Neurosciences · doi:10.1007/7854_2016_466 · Cited by 106
“They have also helped to elucidate how the expression of hallucinogen effects is regulated by a variety of receptors and transporters (González-Maeso et al. 2007, 2008; Canal and Morgan 2012; Nichols 2012).”
BackgroundGlutamate in schizophrenia: Neurodevelopmental perspectives and drug development
Egerton, A., Grace, A. A., Stone, J. M., Bossong, M. G., Sand, M. S., & McGuire, P. K. (2020) · Schizophrenia Research · doi:10.1016/j.schres.2020.09.013 · Cited by 131
“mGluR2/5-HT2A heterodimers (González-Maeso et al., 2008) and D2 / 5-HT2A heterodimers (Łukasiewicz et al.”
Moreno, J. L., Miranda-Azpiazu, P., García-Bea, A., Younkin, J., Cui, M., Kozlenkov, A., Ben-Ezra, A., Voloudakis, G., Fakira, A. K., Baki, L., et al. (2016) · Science Signaling · doi:10.1126/scisignal.aab0467 · Cited by 114
Self-citationClassic Psychedelic Drugs: Update on Biological Mechanisms
Vollenweider, F. X., & Smallridge, J. W. (2022) · Pharmacopsychiatry · doi:10.1055/a-1721-2914 · Cited by 128
“In addition, hallucinogenic and non-hallucinogenic 5-HT2A receptor agonists such LSD and lisuride differentially activate intracellular signal - ing pathways in cortical neurons [94], and only hallucinogenic agonists such as LSD and DOI increased the expression of the early genes EGR1 and EGR-2 [95].”
Metadata
- Authors
- González-Maeso, J., Ang, R. L., Yuen, T., Chan, P., Weisstaub, N. V., López-Giménez, J. F., Zhou, M., Okawa, Y., Callado, L. F., Milligan, G., Gingrich, J. A., Filizola, M., Meana, J. J., & Sealfon, S. C.
- Affiliations
- University of the Basque Country (ES)
- University of Glasgow (GB)
- New York State Psychiatric Institute (US)
- Icahn School of Medicine at Mount Sinai (US)
- Corresponding author
- Sealfon, Stuart C.
- ORCID
- Venue
- Nature
- Published
- 2008-02-24
- Volume
- 452
- Issue
- 7183
- Pages
- 93-97
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC2743172
- OpenAlex
- W2024942419
- Cited by
- 803
- References
- 44
- Citations by year
- 2026: 18 · 2025: 21 · 2024: 23 · 2023: 34 · 2022: 44 · 2021: 38 · 2020: 36 · 2019: 33 · 2018: 45 · 2017: 44 · 2016: 51 · 2015: 37 · 2014: 52 · 2013: 62 · 2012: 71
- FWCI
- 27.83
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (submittedVersion)
- Funders
- National Institute of Mental Health (U01MH083545)
- National Institute on Drug Abuse (T32DA007135, P01DA012923)
- National Institute of General Medical Sciences (T32GM062754)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Keywords
- 5-HT2A receptor, mGluR2, metabotropic glutamate receptors, receptor complex, schizophrenia, psychosis, hallucinogens, LSD, psilocybin, cortical dysfunction, antipsychotic drug targets, postmortem brain
- MeSH terms
- Animals, Brain, Cell Line, Cells, Cultured, Hallucinogens, Humans, Models, Molecular, Protein Binding, Psychotic Disorders, Schizophrenia, Signal Transduction, Down-Regulation, Up-Regulation, Protein Structure, Tertiary, Receptors, Metabotropic Glutamate, Receptor, Serotonin, 5-HT2A, Multiprotein Complexes, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.